Roswell Park’s Division of Translational Immuno-Oncology is designed to bring cutting-edge and novel therapies to you faster.
We have designed our facilities to have all the components necessary for creating and delivering the newest immunotherapy treatment options.
Few institutions in the nation have the facilities for pre-treatment, manufacturing and post-treatment of immunotherapies and gene therapy clinical trials. Our state-of-the-art facilities and expert researchers attract collaborative partnerships with academic institutions and private industry. It is supported by and works cooperatively with numerous Roswell Park departments, including Pathology, Biostatistics, Bioinformatics, and Technology Transfer.
The center comprises three core facilities:
- The cGMP Therapeutic Cell Production Facility (TCPF)
- The Immune Analysis Facility (IAF)
- The Vector Development and Production Facility (VDPF)
By operating our own facilities, we can ensure we are performing at the highest level of quality, and develop better, more personalized care, for you.